Kerry A Whalen

2PUBLICATIONS
2CO-AUTHORS
Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Feb 04, 2026
Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeutics.

Thomas M Schmitt, Kelsey Furiya, Cheryl Black

|Apr 24, 2025
CLN-619, a MICA/B monoclonal antibody that promotes innate immune cell-mediated antitumor activity.

Kerry A Whalen, Catherine C Henry, Naveen K Mehta

Pageof 1